MARKET

IRON

IRON

Disc Medicine Inc
NASDAQ
64.48
-0.76
-1.16%
Opening 11:34 09/28 EDT
OPEN
64.83
PREV CLOSE
65.24
HIGH
65.27
LOW
63.96
VOLUME
98.00K
TURNOVER
--
52 WEEK HIGH
99.50
52 WEEK LOW
40.00
MARKET CAP
2.48B
P/E (TTM)
-9.8163
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IRON last week (0921-0925)?
Weekly Report · 6h ago
Analysts Are Bullish on These Healthcare Stocks: Ligand Pharma (LGND), Disc Medicine (IRON)
TipRanks · 6d ago
Analysts Are Bullish on These Healthcare Stocks: Pacira Pharmaceuticals (PCRX), AMN Healthcare Services (AMN)
TipRanks · 09/21 12:00
Weekly Report: what happened at IRON last week (0914-0918)?
Weekly Report · 09/21 09:09
Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga · 09/16 13:10
Disc Medicine Is Maintained at Overweight by Wells Fargo
Dow Jones · 09/16 12:51
Wells Fargo Maintains Overweight on Disc Medicine, Raises Price Target to $86
Benzinga · 09/16 12:41
Analysts Are Bullish on Top Healthcare Stocks: Stryker (SYK), Disc Medicine (IRON)
TipRanks · 09/16 10:40
More
About IRON
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The Company's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps), including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. It is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.

Webull offers Disc Medicine Inc stock information, including NASDAQ: IRON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IRON stock methods without spending real money on the virtual paper trading platform.